歐普康視(300595.SZ):“硬性接觸鏡潤滑液”首次註冊已完成並獲得第三類醫療器械註冊證
格隆匯2月3日丨歐普康視(300595.SZ)公佈,公司於近日收到國家藥品監督管理局頒發的《中華人民共和國醫療器械註冊證》(註冊證編號:國械注準20233160127)。公司自主研發的硬鏡護理產品“硬性接觸鏡潤滑液”首次註冊已完成並獲得第三類醫療器械註冊證。
該產品為無菌緩衝溶液,內含透明質酸鈉、乳酸鈉、硼酸、硼砂、氯化鈉、聚六亞甲基雙胍和純化水。產品採用過濾除菌無菌灌裝,開瓶拋棄日期為60天,貨架有效期3年。
此次註冊的完成,使得公司可以開始生產和銷售公司自主研發的硬性接觸鏡潤滑液,對公司未來經營將產生積極影響。上述產品的實際銷售情況取決於未來市場推廣效果,目前無法預測其對經營業績的直接影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.